ABL Bio Inc. (298380.KQ)

KRW 27400.0

(-5.03%)

Gross Profit Summary of ABL Bio Inc.

ABL Bio Inc.'s latest annual gross profit in 2023 was 65.5 Billion KRW , down -9.24% from previous year.
ABL Bio Inc.'s latest quarterly gross profit in 2024 Q1 was 1.67 Billion KRW , up 76.02% from previous quarter.
ABL Bio Inc. reported a annual gross profit of 45.56 Billion KRW in annual gross profit 2022, up 314.86% from previous year.
ABL Bio Inc. reported a annual gross profit of -21.2 Billion KRW in annual gross profit 2021, down -578.62% from previous year.
ABL Bio Inc. reported a quarterly gross profit of 4.54 Billion KRW for 2024 Q2, up 171.31% from previous quarter.
ABL Bio Inc. reported a quarterly gross profit of 41.35 Billion KRW for 2023 FY, down -9.24% from previous quarter.

Annual Gross Profit Chart of ABL Bio Inc. (2023 - 2016)

Historical Annual Gross Profit of ABL Bio Inc. (2023 - 2016)

Year	Gross Profit	Gross Profit Growth
2023	65.5 Billion KRW	-9.24%
2022	45.56 Billion KRW	314.86%
2021	-21.2 Billion KRW	-578.62%
2020	-3.12 Billion KRW	36.76%
2019	-4.94 Billion KRW	-120.18%
2018	-2.24 Billion KRW	-36.4%
2017	-1.64 Billion KRW	-834.2%
2016	-176.1 Million KRW	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	1.67 Billion KRW	76.02%
2024 Q2	4.54 Billion KRW	171.31%
2023 FY	41.35 Billion KRW	-9.24%
2023 Q4	952.33 Million KRW	-66.04%
2023 Q3	2.8 Billion KRW	-3.87%
2023 Q2	2.91 Billion KRW	-91.59%
2023 Q1	34.68 Billion KRW	1154.49%
2022 Q1	227.05 Million KRW	105.34%
2022 FY	45.56 Billion KRW	314.86%
2022 Q4	2.76 Billion KRW	-91.8%
2022 Q3	33.72 Billion KRW	201.97%
2022 Q2	11.16 Billion KRW	4817.94%
2021 Q3	-1.62 Billion KRW	-588.56%
2021 Q2	-236.71 Million KRW	77.17%
2021 Q4	-4.25 Billion KRW	-161.06%
2021 Q1	-1.03 Billion KRW	0.0%
2021 FY	-21.2 Billion KRW	-578.62%
2020 FY	-3.12 Billion KRW	36.76%
2019 FY	-4.94 Billion KRW	-120.18%
2018 FY	-2.24 Billion KRW	-36.4%
2017 FY	-1.64 Billion KRW	-834.2%
2016 FY	-176.1 Million KRW	0.0%

Peer Gross Profit Comparison of ABL Bio Inc.

Name	Gross Profit	Gross Profit Difference
Sam Chun Dang Pharm. Co., Ltd	94.48 Billion KRW	30.677%
Hyundai Bioscience Co., Ltd.	5.04 Billion KRW	-1199.314%
ST Pharm Co.,Ltd.	106.62 Billion KRW	38.571%
Cellid, Co., Ltd.	-2.66 Billion KRW	2559.125%